STOCK TITAN

Dividend-linked RSUs granted to Encompass Health (EHC) director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Williams Terrance reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Terrance Williams received 27 restricted stock units (RSUs) as a grant tied to a dividend payment. These RSUs were credited on April 15, 2026, when the company paid a $0.19 per share dividend and the stock closed at $105.24. After this award, Williams directly holds a total of 15,196 shares/RSUs of Encompass Health common stock. The transaction reflects a compensation-related RSU credit rather than an open-market stock purchase.

Positive

  • None.

Negative

  • None.
Insider Williams Terrance
Role Director
Type Security Shares Price Value
Grant/Award Encompass Health Common Stock 27 $0.00 --
Holdings After Transaction: Encompass Health Common Stock — 15,196 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs granted 27 RSUs Dividend-linked award on April 15, 2026
Dividend per share $0.19 per share Common stock dividend paid April 15, 2026
Closing share price $105.24 Encompass Health stock on dividend payment date
Holdings after transaction 15,196 shares/RSUs Direct holdings of Terrance Williams after RSU credit
restricted stock units financial
"additional restricted stock units ("RSUs") are credited to each non-employee director's account"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend payments financial
"RSUs are credited to each non-employee director's account in connection with common stock dividend payments"
dividend record date financial
"number of the RSUs in each director's account on the associated dividend record date"
dividend payment date financial
"divided by (b) the closing price on the dividend payment date"
restricted stock unit award agreements financial
"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Terrance

(Last)(First)(Middle)
9001 LIBERTY PARKWAY

(Street)
BIRMINGHAM ALABAMA 35242

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock04/15/2026A27(1)A$015,196D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
/s/ Patrick Darby, attorney-in-fact for Terrance Williams04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Encompass Health (EHC) report for director Terrance Williams?

Encompass Health reported that director Terrance Williams received 27 restricted stock units (RSUs). These units were granted as a compensation-related award linked to a common stock dividend payment, rather than an open-market share purchase or sale.

Why did Terrance Williams receive 27 RSUs from Encompass Health (EHC)?

The 27 RSUs were credited under existing restricted stock unit award agreements in connection with a dividend. RSUs are added based on the cash dividend amount and the stock’s closing price on the dividend payment date, adjusting directors’ RSU balances when dividends are paid.

What dividend and share price were used for the new RSUs at Encompass Health (EHC)?

The RSU award was based on a $0.19 per share dividend and a $105.24 closing stock price. The company used these figures on April 15, 2026 to calculate how many additional RSUs to credit to non-employee directors’ accounts.

How many Encompass Health (EHC) shares/RSUs does Terrance Williams hold after this Form 4 transaction?

After the RSU credit, Terrance Williams directly holds 15,196 shares/RSUs of Encompass Health common stock. This total reflects his position following the 27 restricted stock units granted in connection with the April 15, 2026 dividend.

Was the Encompass Health (EHC) Form 4 transaction an open-market stock purchase or sale?

No, the transaction was not an open-market trade. It represents a grant of 27 restricted stock units to director Terrance Williams, credited automatically under RSU award agreements in connection with a common stock dividend payment on April 15, 2026.